Immune Pharmaceuticals

OneMedRadio: Immune Pharmaceuticals CEO and Epicept Corporation CEO Discuss Merger

December 4, 2012 OneMedPlace Team 0

Last week, OneMedRadio spoke with Immune Pharmaceuticals founder and CEO Dr. Daniel Teper and Epicept Corporation President and CEO Robert Cook, to discuss the merger and the clinical focus of the merged company going forward.

OneMedRadio: Dr. Daniel Teper of Immune Pharmaceuticals on the Power of Monoclonal Antibodies

July 27, 2012 Herina Ayot 0

IMMUNE Pharmaceuticals is an Israeli and US based emerging leader in the development of antibody therapeutics in cancer and inflammation. IMMUNE has multiple drug candidates based on proprietary cytotoxic formulations, linkers and monoclonal antibodies.

OneMedPlace | Blog

Just another WordPress site

OneMedRadio: Immune Pharmaceuticals CEO and Epicept Corporation CEO Discuss Merger

OneMedRadio: Dr. Daniel Teper of Immune Pharmaceuticals on the Power of Monoclonal Antibodies